Literature DB >> 26683750

Controversies and Advances With Testosterone Therapy: A 40-Year Perspective.

Abraham Morgentaler1.   

Abstract

Testosterone therapy (TTh) has become highly controversial. There are important health consequences of testosterone deficiency, and meaningful benefits with treatment. There is level 1 evidence that TTh improves sexual function and desire, body composition, and bone density. Concerns regarding cardiovascular risk were based on two deeply flawed retrospective studies and are contradicted by dozens of studies showing cardiovascular benefits of TTh or higher endogenous testosterone, including placebo-controlled studies in men with known heart disease (angina, heart failure). Prostate cancer should no longer be considered a risk of TTh. Testosterone is neither scourge nor panacea--it is just good medicine.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26683750     DOI: 10.1016/j.urology.2015.11.034

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  10 in total

Review 1.  Testosterone Therapy Among Prostate Cancer Survivors.

Authors:  Taylor M Nguyen; Alexander W Pastuszak
Journal:  Sex Med Rev       Date:  2016-07-27

Review 2.  Testosterone replacement therapy and the heart: friend, foe or bystander?

Authors:  David S Lopez; Steven Canfield; Run Wang
Journal:  Transl Androl Urol       Date:  2016-12

Review 3.  "Low Testosterone Levels in Body Fluids Are Associated With Chronic Periodontitis".

Authors:  Sergio Varela Kellesarian; Hans Malmstrom; Tariq Abduljabbar; Fahim Vohra; Tammy Varela Kellesarian; Fawad Javed; Georgios E Romanos
Journal:  Am J Mens Health       Date:  2016-09-21

4.  The rate of change in declining steroid hormones: a new parameter of healthy aging in men?

Authors:  Andreas Walther; Michel Philipp; Niclà Lozza; Ulrike Ehlert
Journal:  Oncotarget       Date:  2016-09-20

Review 5.  Current Progress and Controversies in Prostate Cancer Management.

Authors:  De-Xin Dong; Zhi-Gang Ji
Journal:  Chin Med J (Engl)       Date:  2017-12-20       Impact factor: 2.628

6.  Role of androgens for urethral homeostasis.

Authors:  Matthias D Hofer; Allen F Morey
Journal:  Transl Androl Urol       Date:  2018-08

Review 7.  Endogenous and exogenous testosterone and prostate cancer: decreased-, increased- or null-risk?

Authors:  David S Lopez; Shailesh Advani; Konstantinos K Tsilidis; Run Wang; Steven Canfield
Journal:  Transl Androl Urol       Date:  2017-06

Review 8.  Questioning the evidence behind the Saturation Model for testosterone replacement therapy in prostate cancer.

Authors:  Jin Wook Kim
Journal:  Investig Clin Urol       Date:  2020-04-27

9.  A National Analysis of Temporal Changes in Prescribing of Testosterone Replacement Therapy Considering Methods of Delivery and Government Regulation.

Authors:  Andrew Morton; Michael Williams; Marlon Perera; Sachinka Ranasinghe; Patrick E Teloken; Marissa Williams; Eric Chung; Matthew J Roberts
Journal:  World J Mens Health       Date:  2020-07-30       Impact factor: 5.400

Review 10.  The Illusory Case for Treatment of an Invented Disease.

Authors:  David J Handelsman
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-18       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.